Fecal microbiota transplantation (FMT) studies have shown that transferring microbiota from ICI-responsive patients to germ-free or antibiotic-treated mice enhances tumor control, likely by modulating CD8+ T cell responses [194]. The gene discussed is CD8A; the disease is neoplasm.